Bioversys Ag receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Bioversys Ag (BIOV)
Bioversys Ag stock price live, this page displays SIX BIOV stock exchange data. View the BIOV premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Bioversys Ag real time stock price chart below.
What Is the Bioversys Ag Stock Price Today?
The Bioversys Ag stock price today is 25.90.
What Is the Stock Symbol for Bioversys Ag?
The stock symbol for Bioversys Ag is "BIOV."
What Stock Exchange Does Bioversys Ag Trade On?
Bioversys Ag is listed and trades on the Switzerland stock exchange.
Is Bioversys Ag a Good Stock to Buy?
Determining whether Bioversys Ag, or any stock, is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the BIOV quote. (ISIN: CH0210362643)
What Is the Bioversys Ag Stock Price Today?
The Bioversys Ag stock price today is 25.90.
What Is the Stock Symbol for Bioversys Ag?
The stock symbol for Bioversys Ag is "BIOV."
What Stock Exchange Does Bioversys Ag Trade On?
Bioversys Ag is listed and trades on the Switzerland stock exchange.
Is Bioversys Ag a Good Stock to Buy?
Determining whether Bioversys Ag, or any stock, is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the BIOV quote. (ISIN: CH0210362643)
Switzerland
Currency in CHF
25.90
+0.80(+3.19%)
Closed·
Fair Value
An estimate of a Bioversys Ag's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
24.50
25.90
52 wk Range
21.20
30.70
BIOV is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a Bioversys Ag's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
24.5025.90
52 wk Range
21.2030.70
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
BIOV Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Bioversys Ag's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceAnalysts Sentiment
Strong Buy
Price Target
65.80
Upside
+154.05%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Quickly burning through cash
Bioversys Ag receives Investment Bank Analyst Rating Update- Investing.com
Pro
- Bioversys Ag receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- Bioversys Ag receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Bioversys Ag receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Bioversys Ag receives Investment Bank Analyst Rating Update
- Investing.com
Pro 
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy
Analyst Ratings
5 Buy
0 Hold
0 Sell
Ratings:
5 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 65.80
(+154.05% Upside)
Earnings
Latest Release
Sep 09, 2026
EPS / Forecast
-2.66 / -1.71
Revenue / Forecast
2M / 200K
Compare BIOV to Peers and Sector
Metrics to compare | BIOV | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipBIOVPeersSector | |
|---|---|---|---|---|
P/E Ratio | −5.6x | −1.0x | −0.3x | |
PEG Ratio | 1.46 | −0.03 | 0.00 | |
Price/Book | 3.3x | 1.9x | 2.6x | |
Price / LTM Sales | 32.2x | 2.5x | 2.9x | |
Upside (Analyst Target) | 154.1% | 27.0% | 63.9% | |
Fair Value Upside | Unlock | 11.2% | 9.4% | Unlock |
BioVersys AG researches and develops antimicrobial drugs for bacterial infections. It develops BV100 that is in Phase 3 clinical trial for carbapenem-resistant Acinetobacter baumannii lung and bloodstream infections. The company is also developing Alpibectir, which is in Phase 2 clinical trial for the treatment of pulmonary and meningeal tuberculosis; BV200 to treat patients with Gram-positive S. aureus; and BV500 for non-tuberculous mycobacteria infections. It has a research and license option agreement with Shionogi & Co., Ltd. to develop ansamycin leads from the BV500 program into clinical candidates. The company was founded in 2008 and is based in Basel, Switzerland.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Bioversys Ag (BIOV) Stock Price Today?
The Bioversys Ag stock price today is 25.90 CHF.
What Stock Exchange Does Bioversys Ag Trade On?
Bioversys Ag is listed and trades on the Switzerland Stock Exchange.
What Is the Stock Symbol for Bioversys Ag?
The stock symbol for Bioversys Ag is "BIOV."
What Is the Bioversys Ag Market Cap?
As of today, Bioversys Ag market cap is 151.91M CHF.
What Is Bioversys Ag's Earnings Per Share (TTM)?
The Bioversys Ag EPS (TTM) is -4.51.
When Is the Next Bioversys Ag Earnings Date?
Bioversys Ag will release its next earnings report on Dec 02, 2026.
From a Technical Analysis Perspective, Is BIOV a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Sell.
How Many Times Has Bioversys Ag Stock Split?
Bioversys Ag has split 0 times.
How Many Employees Does Bioversys Ag Have?
Bioversys Ag has 38 employees.
What is the current trading status of Bioversys Ag (BIOV)?
As of Oct 14, 2026, Bioversys Ag (BIOV) is trading at a price of 25.90 CHF, with a previous close of 25.90 CHF. The stock has fluctuated within a day range of 24.50 CHF to 25.90 CHF, while its 52-week range spans from 21.20 CHF to 30.70 CHF.
What Is Bioversys Ag (BIOV) Price Target According to Analysts?
The average 12-month price target for Bioversys Ag is 65.80 CHF, with a high estimate of 100 CHF and a low estimate of 40 CHF. 5 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +154.05% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2026 - Fusion Media Limited. All Rights Reserved.